Effect of a novel immunosuppressant, ST1959, on the immune system and renal allograft survival in rats

Transplantation

Volumn 80, Issue 2, 2005, Pages 231-236

  Pezzotta, Anna ^a   Mister, Marilena ^a   Cravedi, Paolo ^a   Azzollini, Nadia ^a   Cassis, Linda ^a   Ruggiero, Vito ^b   DeSantis, Rita ^b   Carminati, Paolo ^b   Remuzzi, Giuseppe ^a   Noris, Marina ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Sigma Tau SpA   (Italy)

Author keywords

3,5 Diaryl s triazole; Immunomodulatory effects; Immunosuppression; Renal allograft; ST1959

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 3 (2 ETHYLPHENYL) 5 (3 METHOXYPHENYL) 1H 1,2,4 TRIAZOLE; CD4 ANTIGEN; CD8 ANTIGEN; CREATININE; IMMUNOSUPPRESSIVE AGENT; STI 1959; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; GRAFT SURVIVAL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; TREATMENT OUTCOME;

ANIMALS; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPH NODES; MALE; ORGAN SIZE; RATS; RATS, INBRED BN; RATS, INBRED LEW; SPLEEN; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS; TRIAZOLES;

EID: 23044468163     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000165434.89700.A7     Document Type: Article

References (14)

1. Vincenti F. A decade of progress in kidney transplantation. Transplantation 2004; 77: S52.
2. Fischereder M, Kretzler M. New immunosuppressive strategies in renal transplant recipients. J Nephrol 2004; 17: 9.
3. Salvadori M, Bertoni E, Rosati A, et al. Post-transplant diabetes mellitus. J Nephrol 2003; 16: 626.
4. Sprague SM, Josephson MA. Bone disease after kidney transplantation. Semin Nephrol 2004; 24: 82.
5. Kirklin JK, Benza RL, Rayburn BK, et al. Strategies for minimizing hyperlipidemia after cardiac transplantation. Am J Cardiovasc Drugs 2002; 2: 377.
6. Galliani G, Assandri A, Gallico L, et al. A new non-hormonal pregnancy-termination agent. Contraception 1981; 23: 163.
7. Mistrello G, Galliani G, Assandri A, et al. Immunological profile of DL111-IT, a new immunosuppressant agent. Immunopharmacology 1985; 10: 163.
8. Assandri A, Oracei-Sale A, Galliani G. A new class of nonhormonal contragestional agents: Pharmacodynamic-pharmacokinetics relationships. Rev Drug Met Drug Interact 1982; 4: 273.
9. Ruggiero V, Albertoni C, Rosi A, et al. Efficacy of ST1959 in murine models of autoimmunity and insights into its peculiar immunomodulatory profile. Int J Immunother 2003; 19: 1.
10. Stasi MA, Ruggiero V, Ursillo A, et al. Ameliorating effects of the immunomodulator 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-IH-1,2,4-triazole in an experimental model of colitis in the rat. Eur J Pharmacol 2004; 494: 263.
11. Noris M, Azzollini N, Mister M, et al. Peripheral donor leukocytes prolong survival of rat renal allografts. Kidney Int 1999; 56: 1101.
12. Chau LA, Rohekart S, Wang JJ, et al. Thymic re-entry of mature activated T cells and increased negative selection in vascularized allograft recipients. Clin Exp Immunol 2002; 127: 43.
13. Matloubian M, Lo CG, Cinamon G, et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004; 22: 355.
14. Perico N, Cattaneo D, Sayegh MH, et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814.